November 9, 2010 (Boston, Massachusetts) — A 4.3% reduction in body weight and an approximate 42% reduction of triglyceride levels in subjects with nonalcoholic fatty liver disease (NAFLD) was ...

Two new small interfering RNA (siRNA) therapeutics (both Arrowhead Pharmaceuticals), each targeting different genes involved in the regulation of triglyceride-rich lipoproteins, have been shown to be ...

When eating, the body converts extra calories, especially from carbs, sugar, fats, and alcohol, into triglycerides.

The evidence for elevated triglycerides, as a cardiac risk factor, is nowhere near as well understood as the risk from high LDL and low HDL cholesterol. However, the growing body of epidemiologic ...